JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2018, Vol. 32 ›› Issue (2): 103-106.doi: 10.6040/j.issn.1673-3770.0.2017.543

Previous Articles     Next Articles

Advances in diagnosis and treatment of polypoid choroidal vasculopathy

WANG Xian1, LI Ying2, ZHAO Bojun3   

  1. Department of Geriatrics, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;3. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2017-12-24 Online:2018-03-20 Published:2018-03-20

PDF (PC)

883

Abstract: Polypoid choroidal vasculopathy(PCV)is characterized by visible orange lesions on fundoscopy. Indocyan-nine green angiograph depicts one or more hyperfluorescent polypoid lesions, with or without abnormal branching vasculature, and also serous and hemorrhagic retinal pigment epithelial detachment. Because of its unique clinical features and higher incidence, increasing attention is being paid to PCV. With advances in science and medical technology, new screening devices, therapies, and drugs are being adopted, all of which has led to a new phase in the understanding, diagnosis, and treatment of PCV. This article reviews the progress of PCV in terms of its diagnosis and treatment.

Key words: Polypoidal choroidal vasculopathy, Diagnosis, Treatment

CLC Number: 

  • R774
[1] Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy(IPCV)[J]. Retina, 1990, 10(1):1-8.
[2] Lim S, Cheung CMG, Wong TY. Asian age-related macular degeneration[J]. Asia Pac J Ophthalmol, 2013, 2(1):32-41.
[3] Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003, 121(10):1392-1396.
[4] Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy:an angiographic discussion[J]. Eye, 2010, 24(3):483-490.
[5] Wong CW, Wong TY. Polypoidal choroidal vasculopathy in Asians[J]. J Clin Med, 2015, 4:782-821.
[6] Wong CW, Yanagi Y, Lee WK, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians[J]. Prog Retin Eye Res, 2016, 53:107-139.
[7] 颜昕,王翠,赵博军. 息肉状脉络膜血管病变的临床表现分析[J]. 山东大学耳鼻喉眼学报,2017,31(4):98-102. YAN Xin, WANG Cui, ZHAO Bojun. Clinical manifestations of polypoidal choroidal vasculopathy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(4):98-102.
[8] Li Y, You QS, Wei WB, et al. Polypoidal choroidal vasculopathy in adult chinese: the Beijing eye study[J]. Ophthalmol, 2014, 121(11):2290-2291.
[9] Koh AH, Chen LJ, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment[J]. Retina, 2013, 33(4):686-716.
[10] Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green(ICG)as related to angiography[J]. Surv Ophthalmol, 2000, 45(1):15-27.
[11] Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review[J]. Surv Ophthalmol, 2010, 55(6): 501-515.
[12] Coppens G, Spielberg L, Leys A. Polypoidal choroidal vasculopathy,diagnosis and management[J]. Bull Soc Belge Ophtalmol, 2011(317):39-44.
[13] Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2005, 89(5): 602-607.
[14] Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography[J]. Retina, 2009, 29(1):52-59.
[15] Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy[J]. Retina, 2007, 27(5):589-594.
[16] De Salvo G, Vaz Pereira S, Keane PA, et al. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2014, 158(6):1228-1238.
[17] Chang YS, Kim JH, Kim JW, et al. Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in korean patients[J]. Kor J Ophthalmol, 2016, 30(3):198.
[18] 张怡,姚静,王肖华,等. 光学相干断层扫描诊断息肉状脉络膜血管病变的敏感性和特异性[J]. 南方医科大学学报,2017,37(2):165-171. ZHANG Yi, YAO Jing, WANG Xiaohua, et al. Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy [J]. J Sout Med Univ, 2017, 37(2):165-171.
[19] Tomiyasu T, Nozaki M, Yoshida M, et al. Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):324-330.
[20] Kim JY, Kwon OW, Oh HS, et al. Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy[J]. Graefes Arch Clin Exp Ophthalmo, 2016, 254(8):1505-1510.
[21] Inoue M, Balaratnasingam C, Freund KB. Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization[J]. Retina, 2015, 35(11):2265-2274.
[22] Wang M, Zhou Y, Gao SS, et al. Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):526-532.
[23] Takayama K, Ito Y, Kaneko H, et al. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy[J]. Eye, 2017, 31(1):45-52.
[24] Wong IY, Shi X, Gangwani R, et al. One-year results of half- versus standard-dose photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy[J]. Retina, 2017. DOI: 10.1097/IAE.0000000000001614.
[25] Hikichi T. Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2018, 102(1):97-101.
[26] 杨景元,王尔茜,陈有信.光动力疗法与玻璃体腔注射抗血管内皮生长因子制剂治疗息肉样脉络膜血管病变的Meta分析[J].中华眼底病杂志,2016,32(1):73-78. YANG Jingyuan, WANG Erqian, CHEN Youxin, et al. Meta-analysis of photodynamic therapy and intravitreal injection of anti-vascular endothelial growth factor agent in the treatment of polypoid choroidal vasculopathy[J]. Chin J Ocul Fund Dis, 2016, 32(1):73-78.
[27] Koh A, Lee WK, Chen LJ, et al. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy[J]. Retina, 2012, 32(8):1453-1464.
[28] Gomi F, Sawa M, Wakabayashi T, et al. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2010, 150(1):48-54.
[29] Koh A, Lai TYY, Takahashi K, et al. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial[J]. JAMA Ophthalmol, 2017, 135(11):1206-1213.
[1] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[2] LU Zhaoyang, ZHAI Zhaoxue, WANG Huikang, SHAO Liting, ZHANG Yu. COVID-19 treatment-induced diabetic ketoacidosis combined with rhino-orbital cerebral mucormycosis: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 90-94.
[3] CHENG Zhuo, LIANG Hui, XING Lumin. Research progress and prospect analysis of deep learning technology in the application of pharyngeal and laryngeal endoscopy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 112-119.
[4] LIU Yijie, LU Xiuzhen, WU Qiuxin. Research rogress of exosomes in the pathogenesis, diagnosis and treatment in ophthalmic diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 135-141.
[5] LI Zan, LU Qi, SHEN Weidong, HOU Zhaohui, WU Nan. Clinical diagnosis and treatment features of 18 cases of necrotizing otitis externa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 17-22.
[6] MA Xiaobao, SHEN Jiali, YANG Jun, CHEN Jianyong, ZHU Songhuan. Exploring the clinical implications of normal VOR gain with refixation saccades in lateral canal [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 40-45.
[7] LIU Ziqi, HUANG Jiali, WANG Liqin, CHEN Xi, ZHANG Liqing, ZHOU Han. Application of narrow band imaging endoscopy combined with voice acoustic analysis in the differential diagnosis of vocal cord leukoplakia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 87-96.
[8] LIU Yuzhu, CHEN Yao, YUAN Tiejun, LI Chunsen, LI Bo. Larynx fibrosarcoma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 133-137.
[9] SUN Shuo, YUAN Tiejun, CHEN Yao, QI Lingling, HAN Rongrong. Misdiagnosis of lingual tuberculosis: a case report and literature veview [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 138-143.
[10] LIU Nanxian, YANG Zeyin, HAN Lin, ZHANG Aiying, ZHAO Yuliang, XUE Jing, SUN Yijun, SHAO Yongliang. Significance of video-EEG in the diagnosis of recurrent vertigo in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 20-25.
[11] GU Zhanxin, ZHAO Zhouyang, ZHANG Xiaobin, YANG Yimei, HUANG Lijin, HUANG Yan. Syndrome differentiation treatment and understanding of traditional Chinese medicine in carotid blowout syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 100-107.
[12] SHI Jinlian, LI Jianxing, HUANG Yousheng, LIN Mingxuan, LIU Lingyun, LU Yongtian. Research status and progress in diagnosis and treatment of laryngeal inflammatory myofibroblastic tumor [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 186-192.
[13] ZHOU Zhihang, LIU Suru, ZHOU Jing, CHEN Dan, YANG Jiajing, LIU Rui, ZHOU Li. Etiology and treatment advances in glottic insufficiency [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 97-103.
[14] WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14.
[15] LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd